Amphastar Pharmaceuticals Inc (NAS:AMPH)
$ 41.3 -1.07 (-2.53%) Market Cap: 2.02 Bil Enterprise Value: 2.41 Bil PE Ratio: 14.29 PB Ratio: 3.00 GF Score: 77/100

Q4 2023 Amphastar Pharmaceuticals Inc Earnings Call Transcript

Feb 28, 2024 / 10:00PM GMT
Release Date Price: $54.74 (-1.26%)
Operator

Greetings, and welcome to the Amphastar Pharmaceuticals' fourth-quarter earnings call. (Operator Instructions) Please note that certain statements made during this call regarding matters that are not historical facts including, but not limited to, management's outlook or predictions for future performance are forward-looking statements. These statements are based solely on information that is now available to us. We encourage you to review the section entitled Forward-Looking Statements in the press release issued today in the presentation on the company's website.

Also, please refer to our SEC filings, which can be found on our website and the SEC's website for a discussion of numerous factors that may impact our future performance. We will also discuss certain non-GAAP measures. Important information on our use of these measures and reconciliations to US GAAP may be found in our earnings release. Please note this conference call is being recorded.

Our speakers today are Mr. Bill Peters, CFO; Mr. Dan Dischner, Senior Vice President of Corporate Communications; Mr. Tony Marrs, Executive

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot